On February 26, 2020 Constellation Pharmaceuticals, Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, reported that Jigar Raythatha, CEO, will present a company overview at the Cowen Health Care Conference in Boston at 1:30 PM EST on Monday, March 2, 2020, and at the Oppenheimer Healthcare Conference in New York City at 10:20 AM EDT on Tuesday, March 17, 2020 (Press release, Constellation Pharmaceuticals, FEB 26, 2020, View Source [SID1234554789]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Live audio webcasts of the presentation and archives for replay will be available on the Investor Relations section of Constellation’s website at View Source The audio webcast replays will be available for 30 days following the live presentation.